Olympus Launches Awareness Initiatives in Support of National Colorectal Cancer Awareness Month

   Olympus Launches Awareness Initiatives in Support of National Colorectal
                            Cancer Awareness Month

Leader in GI Endoscopy Promotes Screening for Colorectal Cancer that Affects
Millions of Americans Nationwide

PR Newswire

CENTER VALLEY, Pa., March 10, 2014

CENTER VALLEY, Pa., March 10, 2014 /PRNewswire/ --Olympus, a precision
technology leader in designing and delivering innovative solutions in Medical
and Surgical Products, among other core businesses, announced today its
efforts in promoting National Colorectal Cancer (CRC) Awareness Month. March
2014 marks the 15th annual National CRC Awareness Month, observed annually to
educate the community on this prevalent disease and promote awareness for
cancer screening, prevention and testing. Primary among the initiatives is
its partnership with Dr. Douglas Rex, a nationally-recognized colonoscopy
expert and pioneer.

Colorectal cancer continues to be a major health issue: Of cancers that affect
both men and women, colorectal cancer is the second leading cause of
cancer-related deaths in the U.S. (Centers for Disease Control). Nearly
143,000 Americans will be diagnosed with colon cancer this year, and an
estimated 51,000 people will die from it (American Cancer Society). The cost
to care for colorectal cancer is estimated to be more than $50,000 in the
first year of diagnosis alone (National Cancer Institute).

Colorectal cancer is preventable with early and regular screening. The U.S.
Preventive Services Task Force (USPSTF) recommends screening for colorectal
cancer by one of several tests, including a colonoscopy, beginning at age 50
years and continuing until age 75 years. Still only about 60 percent of
American adults aged 50 and older get screened for colorectal cancer (American
College of Physicians).

To improve the percentage of patients who are recommended for screening,
actually seeking it out, many organizations promote awareness about the
disease's dangers and preventability. Among Olympus' activities during this
important health awareness month are:

  oPartnering with Professor Douglas Rex, M.D. on a satellite TV and radio
    media tour to provide interviews nationwide about the benefits of
    screening for colorectal cancer. In addition, Dr. Rex will discuss the
    importance of colonoscopy in early detection and treatment of colorectal
    cancer.
  oSponsoring a Colon Cancer Coalition "Get Your Rear in Gear" 4-mile run to
    raise cancer awareness and positively impact screening rates, Sunday March
    23 in Philadelphia. Registration information is available at:
    http://getyourrearingear.com/events/list/2014/philadelphia-pa-2014/
  oHosting a CRC educational event at Olympus with Dr. Steven Lichtenstein,
    Director of the Division of Gastroenterology at Philadelphia's Mercy
    Fitzgerald Hospital, scheduled for March 21st at the Olympus' Center
    Valley headquarters for the Americas. Dr. Lichtenstein will educate
    participants about the disease and share compelling patient stories of
    colon cancer survival.
  oMotivating employees to become educators about the importance of
    colorectal screening within the community. For example, Olympus is
    empowering employees to discuss CRC screening with friends and family
    through a variety of educational materials such as palm cards and magnets.

"Colonoscopy is considered the gold standard of screening for early detection
and prevention of colorectal cancer," said Dr. Douglas Rex, Distinguished
Professor of Medicine, Indiana University, MD, FACP, AGAF, FACG, FASGE. "A
colonoscopy can find precancerous polyps so they can be removed before they
turn into cancer. I'm pleased to help Olympus spread the word about prevention
and intervention."

As one of the top colonoscopy experts in the world, Professor Douglas Rex
organized the first trial of using colonoscopy to screen average-risk
individuals in 1987. In this trial, nearly 800 asymptomatic health
professionals and their spouses underwent screening colonoscopy. This trial,
along with the dozens of other investigations Rex has produced over the past
two decades, helped transform colonoscopy from an uncommon and potentially
dangerous procedure to the most effective screening test against any form of
internal cancer and one of the most widely performed medical procedures in the
United States.

Olympus is the leading manufacturer of medical devices used to peer inside the
human body to detect, diagnose and treat gastrointestinal diseases such as
colorectal cancer. Olympus pioneered the development of endoscopic technology
more than 50 years ago and remains a global leader today, helping to improve
the lives of millions who have been diagnosed or screened for colorectal
cancer. More information about Colorectal Cancer Awareness Month is available
at www.CRCawareness.com.

About Olympus Medical Systems Group

Olympus Medical Systems Group, a division of global technology leader Olympus,
develops solutions for healthcare professionals that help improve clinical
outcomes, reduce overall costs and enhance quality of life for their patients.
By enabling less invasive procedures and innovative diagnostic and therapeutic
endoscopy, Olympus is transforming the future of healthcare.

For more information visit Olympus at www.medical.olympusamerica.com.

SOURCE Olympus

Website: http://www.medical.olympusamerica.com
Contact: Michael Levey, Olympus Corporation of the Americas, 484-896-5120,
michael.levey@olympus.com
 
Press spacebar to pause and continue. Press esc to stop.